Cold, Flu & Cough News and Research

Latest Cold, Flu & Cough News and Research

GenVec signs new agreement with Novartis for supply of services relating to development materials

GenVec signs new agreement with Novartis for supply of services relating to development materials

Research Roundups: Expanding Medicaid; More spending doesn't reduce mortality; Colonoscopy cost effectiveness; Kids, asthma and access to care

Research Roundups: Expanding Medicaid; More spending doesn't reduce mortality; Colonoscopy cost effectiveness; Kids, asthma and access to care

Need for trained medical professionals to treat medical emergencies in high school athletes

Need for trained medical professionals to treat medical emergencies in high school athletes

GenVec reports net loss of $4.2M for second-quarter 2010

GenVec reports net loss of $4.2M for second-quarter 2010

Akonni Biosystems receives patent for TruTip Extraction Kits

Akonni Biosystems receives patent for TruTip Extraction Kits

BioCryst second-quarter total revenues increase to $7.6 million

BioCryst second-quarter total revenues increase to $7.6 million

CEL-SCI produces and fills first lot of Multikine

CEL-SCI produces and fills first lot of Multikine

Americans stop seeking medical care for recent illness, survey reveals

Americans stop seeking medical care for recent illness, survey reveals

Merck's two pivotal boceprevir Phase III registration studies for chronic HCV meet primary endpoint

Merck's two pivotal boceprevir Phase III registration studies for chronic HCV meet primary endpoint

Genzyme, Isis announce results of two mipomersen phase 3 studies

Genzyme, Isis announce results of two mipomersen phase 3 studies

Alnylam second-quarter revenues increase to $26.6 million

Alnylam second-quarter revenues increase to $26.6 million

NanoBio Corporation receives U.S. patent for nanoemulsion technology

NanoBio Corporation receives U.S. patent for nanoemulsion technology

Foldit players to focus on designing novel proteins

Foldit players to focus on designing novel proteins

Scientist invents new approach to boost body's response to vaccinations

Scientist invents new approach to boost body's response to vaccinations

Review affirms hand therapy as one of most vital treatment steps in recovery from hand injury surgery

Review affirms hand therapy as one of most vital treatment steps in recovery from hand injury surgery

PCV-7 vaccine introduction leads to changing patterns of hemolytic uremic syndrome

PCV-7 vaccine introduction leads to changing patterns of hemolytic uremic syndrome

Matrixx Initiatives first-quarter net loss reduces to $2.4 million

Matrixx Initiatives first-quarter net loss reduces to $2.4 million

Victory Pharma acquires assets of MiddleBrook Pharmaceuticals

Victory Pharma acquires assets of MiddleBrook Pharmaceuticals

ICU Medical's Neutron Neutral-Pressure Needleless Connector receives FDA clearance

ICU Medical's Neutron Neutral-Pressure Needleless Connector receives FDA clearance

Vical second-quarter revenues decrease to $2.1 million

Vical second-quarter revenues decrease to $2.1 million

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.